ARCHIVES

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

May 2, 2008

Treatment Doesn’t Always Follow Recommendations

February 25, 2005

In Brief: NCI To Go Along With NCAB on Keeping Clinical Education Program Alive; Cal Baldwin Retires

February 28, 1986

HPV DNA Testing Reduced Cervical Cancer Precursors

September 24, 2010

Patient Advocacy: congress Delivers Symbolism, Not Solution, Visco Says

October 17, 1997

In Brief: Former PHS Official Jeffrey Koplan To Head CDC; Caligiuri Wins Freireich Award

July 17, 1998